Human medicines European public assessment report (EPAR): Accofil, filgrastim, Date of authorisation: 17/09/2014, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Bortezomib Hospira, bortezomib, Date of authorisation: 22/07/2016, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Matever, levetiracetam, Date of authorisation: 03/10/2011, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Fingolimod Accord, fingolimod, Date of authorisation: 25/06/2020, Revision: 9, Status: Authorised

EVVET – Data warehouse user manual

Opinion on medicine for use outside EU: Mosquirix, RTS,S [Portion of P. falciparum circumsporozoite protein fused with hepatitis B surface antigen (RTS), and combined with hepatitis B surface antigen (S)], Malaria, 23/07/2015 Positive opinion

ETF recommends updating COVID-19 vaccines to target new LP.8.1 variant

EMA recommendation to update the antigenic composition of authorised COVID-19 vaccines for 2025-2026

Human medicines European public assessment report (EPAR): Deqsiga, human normal immunoglobulin, Date of authorisation: 02/05/2025, Status: Authorised

Confidentiality undertaking for observers